JP2024525239A5 - - Google Patents

Info

Publication number
JP2024525239A5
JP2024525239A5 JP2023563075A JP2023563075A JP2024525239A5 JP 2024525239 A5 JP2024525239 A5 JP 2024525239A5 JP 2023563075 A JP2023563075 A JP 2023563075A JP 2023563075 A JP2023563075 A JP 2023563075A JP 2024525239 A5 JP2024525239 A5 JP 2024525239A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
polyoxyethylene
castor oil
cerebral infarction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023563075A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024525239A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/025462 external-priority patent/WO2022226013A1/en
Publication of JP2024525239A publication Critical patent/JP2024525239A/ja
Publication of JP2024525239A5 publication Critical patent/JP2024525239A5/ja
Pending legal-status Critical Current

Links

JP2023563075A 2021-04-20 2022-04-20 化合物smtp-7を含有する医薬組成物 Pending JP2024525239A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021070892 2021-04-20
JP2021070892 2021-04-20
PCT/US2022/025462 WO2022226013A1 (en) 2021-04-20 2022-04-20 Pharmaceutical composition comprising the compound smtp-7

Publications (2)

Publication Number Publication Date
JP2024525239A JP2024525239A (ja) 2024-07-11
JP2024525239A5 true JP2024525239A5 (cg-RX-API-DMAC7.html) 2025-04-30

Family

ID=81648879

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023563075A Pending JP2024525239A (ja) 2021-04-20 2022-04-20 化合物smtp-7を含有する医薬組成物

Country Status (9)

Country Link
US (1) US20240238252A1 (cg-RX-API-DMAC7.html)
EP (1) EP4326258A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024525239A (cg-RX-API-DMAC7.html)
KR (1) KR20230173129A (cg-RX-API-DMAC7.html)
CN (1) CN117279634A (cg-RX-API-DMAC7.html)
AU (1) AU2022262593A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023021803A2 (cg-RX-API-DMAC7.html)
CA (1) CA3214630A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022226013A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240238248A1 (en) * 2021-05-10 2024-07-18 Ji Xing Pharmaceuticals Hong Kong Limited Pharmaceutical composition for use in treating cerebral infarction
WO2026092761A1 (zh) * 2024-11-04 2026-05-07 江苏恒瑞医药股份有限公司 包含smtp衍生物的药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004224737A (ja) 2003-01-23 2004-08-12 Ttc:Kk 新規トリプレニルフェノール化合物
JP4313049B2 (ja) 2003-01-23 2009-08-12 株式会社ティーティーシー 血管新生関連疾患の予防又は治療用医薬組成物
JPWO2007040082A1 (ja) 2005-10-06 2009-04-16 国立大学法人東京農工大学 腎炎治療又は予防用医薬組成物及びその製造方法
KR20080112184A (ko) 2006-03-27 2008-12-24 노우코우다이 티엘오 가부시키가이샤 트리프레닐페놀화합물과 트리프레닐페놀화합물의 제조방법,및 혈전용해촉진제
JP2008201688A (ja) * 2007-02-16 2008-09-04 Tms Co Ltd 皮膚老化防止剤、化粧料及び皮膚外用剤
JP5605659B2 (ja) * 2009-07-06 2014-10-15 国立大学法人東京農工大学 細胞保護剤
WO2011125930A1 (ja) 2010-04-02 2011-10-13 日本製薬株式会社 炎症性腸疾患又は自己免疫性の末梢神経障害の予防又は治療剤
JP7381035B2 (ja) * 2018-11-02 2023-11-15 学校法人昭和大学 Smtp一群又はsmtp-7の製造中間体及びその化学的製造方法
US20240238248A1 (en) * 2021-05-10 2024-07-18 Ji Xing Pharmaceuticals Hong Kong Limited Pharmaceutical composition for use in treating cerebral infarction

Similar Documents

Publication Publication Date Title
JP7130818B2 (ja) 特異的炎症収束性メディエーターの塩に関連する組成物及び方法
HRP20241643T1 (hr) Derivati masnih kiselina za liječenje nealkoholnog steatohepatitisa
JP2012526094A5 (cg-RX-API-DMAC7.html)
JP2022529720A (ja) レナリドミドまたは他の免疫調節剤の持続投与
JP2023518035A5 (cg-RX-API-DMAC7.html)
JP2024544415A5 (cg-RX-API-DMAC7.html)
JP2023522065A5 (cg-RX-API-DMAC7.html)
JP2018515463A5 (cg-RX-API-DMAC7.html)
JP2022510587A5 (cg-RX-API-DMAC7.html)
JP2022511730A5 (cg-RX-API-DMAC7.html)
JP2024523411A5 (cg-RX-API-DMAC7.html)
JP3802105B2 (ja) ジクロフェナクナトリウム含有乳化外用剤
US8168670B2 (en) Pyrazolone derivative emulsion formulations
TW202228706A (zh) 穩定之醫藥組合物
JP2022519317A5 (cg-RX-API-DMAC7.html)
JP2022538505A5 (cg-RX-API-DMAC7.html)
JP4866546B2 (ja) ジクロフェナク含有乳剤性軟膏剤
JP6908449B2 (ja) 医薬組成物
KR20220161356A (ko) 자발적 수용이 개선된 조성물
TWI387586B (zh) 吡唑酮衍生物調配物
JP2006509038A5 (cg-RX-API-DMAC7.html)
RU2014141341A (ru) Паралитический яд моллюсков
JP4843824B2 (ja) 外用剤
WO2020241605A1 (ja) 外用剤
TW201630606A (zh) 包含局部藥物之蓋崙(galenic)調配物